Particulate composite materials and devices comprising the same are provided.

Particulate composite materials and devices comprising the same are provided.

Provided is a method of producing an integral 3D humic acid-carbon hybrid foam, comprising: (A) forming a solid shape of humic acid-polymer particle mixture; and (B) pyrolyzing the solid shape of humic acid-polymer particle mixture to thermally reduce humic acid into reduced humic acid sheets and thermally convert polymer into pores and carbon or graphite that bonds the reduced humic acid sheets to form the integral 3D humic acid-carbon hybrid foam.

An activated carbon manufacturing method may include preparing activated carbon precursors, carbonizing the activated carbon precursors by performing a heat treatment on the activated carbon precursors, equalizing the activated carbon precursors which were carbonized, in the carbonizing, by grinding the activated carbon precursors, activating the activated carbon precursors by inserting an oxidizing agent and distilled water into the equalized activated carbon precursors, and performing a heat treatment on the activated carbon precursors, and introducing a nitrogen-based functional group into a surface of the activated carbon precursors by mixing the activated carbon precursors, a nitrogen material, and a solvent to perform reaction on the activated carbon precursors.

An activated carbon manufacturing method may include preparing activated carbon precursors, carbonizing the activated carbon precursors by performing a heat treatment on the activated carbon precursors, equalizing the activated carbon precursors carbonized, in the carbonizing, by grinding the activated carbon precursors, activating the activated carbon precursors by inserting an oxidizing agent and distilled water into the equalized activated carbon precursors and performing a heat treatment on the activated carbon precursors, and introducing metal oxide particles into the activated carbon precursors by mixing the activated precursors, a metal salt, and a reducing agent in a solvent to perform reaction on the activated carbon precursors.

Carbon-carbon nanotube (CNT) hybrid materials, and methods of producing the hybrid materials. The hybrid materials include carbon particles and CNTs on the surface of the particles. The CNT comprises more than about 3.2 weight percent of the hybrid material.

A filter apparatus for removing small molecule chemotherapy agents from blood is provided. The filter apparatus comprises a housing with an extraction media comprised of polymer coated carbon cores. Also provided are methods of treating a subject with cancer of an organ or region comprising administering a chemotherapeutic agent to the organ or region, collecting blood laded with chemotherapeutic agent from the isolated organ, filtering the blood laden with chemotherapeutic agent to reduce the chemotherapeutic agent in the blood and returning the blood to the subject.

A filter apparatus for removing small molecule chemotherapy agents from blood is provided. The filter apparatus comprises a housing with an extraction media comprised of polymer coated carbon cores. Also provided are methods of treating a subject with cancer of an organ or region comprising administering a chemotherapeutic agent to the organ or region, collecting blood laded with chemotherapeutic agent from the isolated organ, filtering the blood laden with chemotherapeutic agent to reduce the chemotherapeutic agent in the blood and returning the blood to the subject.

Provided is a granular activated carbon having many mesopores that can be used for applications similar to sine chloride-activated carbons, and also provided is a method for manufacturing the same. The granular activated carbon is obtained by bringing an activated carbon into contact with a calcium component, followed by activation and washing.

The present invention relates to a coconut shell-derived modified activated carbon having a BET specific surface area of 1400 to 2000 m.sup.2/g, a value of hydrogen content/carbon content of 0.0015 to 0.0055, and intra-skeletal oxygen of 0.9 mass % or less.